Bausch Health Companies BHC Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's noncontrolling interests in subsidiaries?
- Bausch Health Companies (BHC) reported noncontrolling interests in subsidiaries of $977M in Q1 2026.
- How has Bausch Health Companies's noncontrolling interests in subsidiaries changed year-over-year?
- Bausch Health Companies's noncontrolling interests in subsidiaries increased by 3.6% year-over-year, from $943M to $977M.
- What is the long-term trend for Bausch Health Companies's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Bausch Health Companies's noncontrolling interests in subsidiaries has grown at a 67.8% compound annual growth rate (CAGR), from $70M to $931M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.